| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 28-Dec-08 | | Total Revenue | 437,065 | 434,575 | 431,574 | 421,369 | | Cost of Revenue | 249,495 | 247,102 | 243,619 | 219,641 | | | Gross Profit | 187,570 | 187,473 | 187,955 | 201,728 | | | Operating Expenses | | Research Development | 27,336 | 25,568 | 25,973 | 21,528 | | Selling General and Administrative | 121,431 | 123,962 | 128,414 | 116,666 | | Non Recurring | 12,383 |
-
| 7,823 | (719) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,420 | 37,943 | 25,745 | 64,253 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 48 | (249) | (22,514) | | Earnings Before Interest And Taxes | 12,782 | 37,991 | 25,496 | 41,739 | | Interest Expense | (8,817) | 4,229 | 4,588 | 6,787 | | Income Before Tax | 21,599 | 33,762 | 20,908 | 34,952 | | Income Tax Expense | 5,578 | 10,807 | 5,847 | 7,734 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,021 | 22,955 | 15,061 | 27,218 | | | Non-recurring Events | | Discontinued Operations | (2,432) | (1,450) | (4,502) | 3,445 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,589 | 21,505 | 10,559 | 30,663 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,589 | $21,505 | $10,559 | $30,663 |
|
0.22% Nasdaq 0.00%
Income Statement
